A single-centre retrospective review of treatment responses and adverse events of thalidomide in patients with inflammatory skin disease

Clin Exp Dermatol. 2024 Jan 25;49(2):168-170. doi: 10.1093/ced/llad294.
No abstract available

MeSH terms

  • Dermatitis*
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Multiple Myeloma*
  • Retrospective Studies
  • Thalidomide / adverse effects

Substances

  • Thalidomide
  • Immunosuppressive Agents